Comparison of Early and Late Administration of Convalescent Plasma for the Treatment of COVID-19 Patients Hospitalized in Intensive Care Unit Retrospectively Yogun Bakimda Yatan COVID-19'lu Hastalarin Tedavisinde Erken ve Geç Dönem Konvalesan Plazma Uygulamalarinin Retrospektif Olarak Karsilastirilmasi


Creative Commons License

Çalili D. K., Atsal A. Ö., Akan B. T., Ankarali H., Gönen C. Ç., Turan I. Ö.

Anestezi Dergisi, cilt.31, sa.1, ss.11-20, 2023 (Scopus, TRDizin) identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 31 Sayı: 1
  • Basım Tarihi: 2023
  • Doi Numarası: 10.54875/jarss.2023.38233
  • Dergi Adı: Anestezi Dergisi
  • Derginin Tarandığı İndeksler: Scopus, Academic Search Premier, Central & Eastern European Academic Source (CEEAS), EMBASE, TR DİZİN (ULAKBİM)
  • Sayfa Sayıları: ss.11-20
  • Anahtar Kelimeler: convalescent plasma, COVID-19, Intensive care unit, mortality
  • Açık Arşiv Koleksiyonu: AVESİS Açık Erişim Koleksiyonu
  • Ankara Üniversitesi Adresli: Evet

Özet

Objective: We aimed to compare laboratory and outcome of the patients who were hospitalized in the intensive care unit with the diagnosis of Coronavirus Disease-19 (COVID-19) and transfused convalescent plasma based on timing of treatment. Methods: Patients administered 200 mL of convalescent plasma were analysed retrospectively. Based on symptoms' onset, patients were divided into two groups as early (≤ 7 days) and late (> 7 days) plasma treatment groups. Patients' characteristics, comorbidities, treatments, laboratory (pre-transfusion, day 1 and day 3 after transfusion) and outcome were evaluated according to groups. Results: A total of 152 patients matched criteria. There was no difference between the early (n=82) and late (n=70) treatment groups in terms of demographic characteristics, comorbidities, treatments, outcomes. Ferritin levels were higher in the early treatment group than in the late treatment group on before transfusion and day 1 (p=0.023, p=0.015). C reactive protein value was lower in the late treatment group on day 3 (p=0.011). Comparing the rate of change between day 1 and day 3 of treatment, it was observed that the changes in ferritin and fibrinogen values were higher in the late group than in the early group (p=0.014, p=0.049). There was no difference between the groups in other laboratory values and outcome. Conclusion: In our study, we observed that the timing of convalescent plasma had no significant effect on outcome. However, more evidence was needed to prove the difference in laboratory results.